Dr Tripathi is a Senior Consultant Clinical Oncologist at Nuffield Health Wolverhampton Hospital, The Royal Wolverhampton NHS Trust, and Dudley Group of Hospitals NHS Trust. He trained in Oncology at Weston Park Hospital, Sheffield, completing his specialist training in 2015. Specialising in Breast, Head and Neck and Thyroid cancers, Dr Tripathi has extensive experience and expertise in systemic chemotherapy, Immunotherapy, novel agents, and advanced radiotherapy techniques.
Breast Cancers, Head and Neck Cancers and Thyroid Cancers- Radiotherapy, Chemotherapy, Immunotherapy and Targeted Systemic Therapy
Stereotactic Ablative Radiotherapy (Primary and Oligometastatic Lung tumours)
English, Hindi, Urdu
Dr Tripathi has been the site Principal investigator and Co-Investigator for several Multicentre Clinical trials.
Currently, he is the Principal Investigator at Dudley Group of Hospitals for the PARTNER Breast Cancer trial, the ADD-ASPIRIN trial and the ‘Chemo Brain’ study, and Co-Investigator for the OPTIMA breast cancer trial.
- Membership of the Royal College of Physicians, UK (MRCP UK)
- Fellowship of the Royal College of Radiologists, UK (FRCR UK)
- Association of Radiation Oncologists of India (AROI)- Life Member
Other posts held
- Consultant in Clinical Oncology at The Royal Wolverhampton NHS Trust and Dudley Group of Hospitals
Insurers Dr Devashish Tripathi works with
Dr Devashish Tripathi works with the following private medical insurance providers:
- Aviva Health
- AXA Health
- AXA - Global Healthcare
Dr Devashish Tripathi does not hold a share or financial interest in this hospital, another Nuffield Health hospital or the company.
Dr Devashish Tripathi does not have a share or financial interest in equipment used at this hospital or another Nuffield Health hospital.
Dr Devashish Tripathi does not hold any paid advisory role(s) at this hospital or on behalf of Nuffield Health.